I A L S N 

Home

About Us

Our Vision

Our Team

Membership

Sponsorship

Calendar of Events

The Power of Outsourcing

Newsletters

Photo Gallery

Presentations

Jobs & Candidates

Forms

Contact US

Iranian American Life Science Network
Dr. Kourosh Parivar
Dr. Kourosh Parivar

IALSN is proud to present

 
 "Clinical Trials: Phase II"

Guest Speaker
Dr. Kourosh Parivar, M.Pharm.
Vice President
Head, Clinical Pharmacology
Oncology Business Unit

Pfizer Inc.

 

In this talk Phase II studies specifically Proof of Concept (POC) studies will be described and put in relationship to the overall context of Drug Development. Different design alternatives will be explained and topics such as fixed design versus adaptive design will be explained.

 

May 27, 2010

Dr. William Gerwick

Dr. Gerwick talked about “Prospecting for Pharmaceuticals on Coral Reefs: Interesting Science and Educational Opportunities with Societal Applications”. Dr. Gerwik is the professor of Oceanography and Pharmaceutical Sciences Center for Marine Biotechnology and Biomedicine at Scripps Institution of Oceanography, University of California at San Diego. He received his B.S. degree in Biochemistry at the University of California, Davis. His undergraduate Research was in Phycology. He received his Ph.D. from University of California, San Diego Scripps Institution of Oceanography, and was a Postdoctoral Research Associate at the University of Connecticut, School of Pharmacy. 
 
February, 4 2010
Dr. James McKim
Dr. James McKim

IALSN is proud to present

 
"Organotypic In Vitro Models for Accessing the Safety of Pharmaceutical Candidates: An Ala Carte Approach to Screening"  

Dr. Jim McKim
A Diplomat of the American Board of Toxicology
The Founder and Chief Scientific Officer of CeeTox, Inc  

The talk will be focused on a large battery of assays that monitor key biochemical processes and signaling pathways by using new human cell models for liver and kidney that enable teams to monitor normal physiological parameters as well as toxicity pathways.   Three models (liver, kidney, and heart) that focus on target organ specific toxicity will be presented. Assays and cell models that are currently available will be shown as well as new assays in the CeeTox pipeline. In addition, a new real time application called “Study Building” will be demonstrated. This program allows teams to design their own studies based on their immediate needs.  The program provides and allows users to select cell type, assay, exposure concentrations, replicates, and many other variables that determine study scope and cost.  

December 10, 2009
Pardis Sabeti 
Emancipation, Revolution, and Oppression 

By Dr. Massoum Montakhab

January 29, 2009
 
 Comprehensive Facial Rejuvenation
 by Dr. Amir Karam, MD

September 18, 2008
 
Future Prospects of Dementia  & The New Horizons of Research on the Aging Mind
 by Dr. A. Dean Sherzai
June 10, 2008
 

Patenting and Intellectual Property Rights
 by Dr. Sam Tahmassebi
April 30, 2008
 
From Physics to Pharma: New Tools and Protocols to Maximize Phase I Clinical Trials
by Dr. Ali Arjomand
January 30, 2008


 
 
HIBM
Hereditary Inclusion Body Myopathy 
Daniel K. Darvish, MD
December 12, 2007
This is Dr. Daniel Darvish presentation on HIBM, the rare/orphan disease, therapeutic staratgies, and hope for future. 
Document
HIBM
 
 

History of Medicine in Iran
This is a brief overview  of history of Medicine in Iran. Dr. Mehran Moghadam researched and prepared this beautiful presentation for our March 2007 event.

Document

Copyright  © 2006, IALSN. All Reserved.

Providing a Rich & Focused Network to Life & Medical Science Community